Literature DB >> 7372794

Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.

M E Quigley, S J Judd, G B Gilliland, S S Yen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372794     DOI: 10.1210/jcem-50-6-994

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  12 in total

Review 1.  Hyperprolactinemia: neuroendocrine and diagnostic aspects.

Authors:  F Camanni; E Ciccarelli; E Ghigo; E E Müller
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

2.  Reduced number of natural killer cells in patients with pathological hyperprolactinemia.

Authors:  R Gerli; P Rambotti; I Nicoletti; S Orlandi; G Migliorati; C Riccardi
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Prolactinoma: a question of rational treatment.

Authors:  C R Edwards; C M Feek
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

4.  Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.

Authors:  G M Prelević; M I Würzburger; L A Perić
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

Review 5.  Pituitary microadenomas: diagnostic and therapeutic trends.

Authors:  E M Grimes
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

6.  Pituitary secretion after administration of a new cerebroactive drug, fipexide.

Authors:  E Rolandi; R Franceschini; A Marabini; V Messina; P Bongera; T Barreca
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.

Authors:  G M Prelević; M I Würzburger; L A Perić
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

8.  The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.

Authors:  R W Prescott; D G Johnston; P K Taylor; J Haigh; D R Weightman; K Hall; D B Cook
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

9.  Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.

Authors:  E Ghigo; E Ciccarelli; A Novelli; M Massobrio; E E Müller; F Camanni
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

10.  Prolactin-secreting pituitary adenomas.

Authors:  M C Martin; E D Schriock; R B Jaffe
Journal:  West J Med       Date:  1983-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.